No OS improvement over chemo from capivasertib plus paclitaxel in advanced TNBC

Mutational-based treatment approach may significantly improve outcomes in pretreated patients with metastatic solid tumours

ESMO 2024: Latest in EGFR mutated NSCLC

Retifanlimab plus chemo shows PFS benefit in recurrent or metastatic squamous cell carcinoma of the anal canal

Understanding the use of PARPi combinations to treat patients with mCRPC

TACE combined with lenvatinib-pembrolizumab shows improved PFS in intermediate stage liver cancer

ESMO 2024: Optimising the personalisation of prostate cancer treatment

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer

NKT2152 demonstrates anti-tumor activity in heavily pretreated advanced clear cell RCC

Status of anti BCMA therapy in myeloma

The promise of CAR T cell therapy for multiple myeloma